Related Experiment Video
Updated: Jan 23, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
miR-522 stimulates TGF-β/Smad signaling pathway and promotes osteosarcoma tumorigenesis by targeting PPM1A
1Department of Spine Surgery, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.
Abstract:
Osteosarcoma (OS) is identified as an aggressive malignancy of the skeletal system and normally occurs among young people. It is well accepted that microRNAs are implicated in biological activities of diverse tumors. Although miR-522 has been proved to elicit oncogenic properties in a wide range of human cancers, the physiological function and latent mechanism of miR-522 in OS tumorigenesis remain largely to be probed. In the current study, we certified that miR-522 was highly expressed in OS cells and presented carcinogenic function by contributing to cell proliferation, migration, and EMT progression whereas dampening cell apoptosis. In addition, miR-522 provoked TGF-β/Smad pathway through targeting PPM1A. Finally, the results of mechanism experiments elucidated that miR-522 stimulated TGF-β/Smad pathway to induce the development of OS via targeting PPM1A, which exposed that miR-522 may become a promising curative target for OS patients.
Insights
MicroRNA-522 (miR-522) drives osteosarcoma (OS) growth and spread by activating the TGF-β/Smad pathway. Targeting miR-522 shows potential for treating this aggressive bone cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Osteosarcoma (OS) is an aggressive bone cancer primarily affecting young individuals.
- MicroRNAs (miRNAs) are crucial regulators of gene expression implicated in various cancers.
- The specific role and mechanism of miR-522 in OS development are not well understood.
Purpose of the Study:
- To investigate the function and mechanism of miR-522 in osteosarcoma tumorigenesis.
- To explore the potential of miR-522 as a therapeutic target for OS.
Main Methods:
- Quantitative real-time PCR to assess miR-522 expression levels in OS cells.
- Cell proliferation, migration, and apoptosis assays to evaluate miR-522's functional role.
- Western blotting and luciferase reporter assays to elucidate the molecular mechanism involving the TGF-β/Smad pathway and PPM1A.
Main Results:
- miR-522 was significantly upregulated in osteosarcoma cells.
- Overexpression of miR-522 promoted cell proliferation, migration, and epithelial-mesenchymal transition (EMT), while inhibiting apoptosis.
- miR-522 was found to target PPM1A, thereby activating the TGF-β/Smad signaling pathway.
Conclusions:
- miR-522 plays a carcinogenic role in osteosarcoma development by promoting cell growth, invasion, and EMT via the TGF-β/Smad/PPM1A axis.
- miR-522 represents a potential diagnostic biomarker and therapeutic target for osteosarcoma.
Related Concept Videos
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Insulin: The Receptor and Signaling Pathways
IP3/DAG Signaling Pathway

